BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33299310)

  • 1. Oral Exposure to ZnO Nanoparticles Disrupt the Structure of Bone in Young Rats via the OPG/RANK/RANKL/IGF-1 Pathway.
    Xu X; Tang Y; Lang Y; Liu Y; Cheng W; Xu H; Liu Y
    Int J Nanomedicine; 2020; 15():9657-9668. PubMed ID: 33299310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heamatococcus pluvialis ameliorates bone loss in experimentally-induced osteoporosis in rats via the regulation of OPG/RANKL pathway.
    El-Baz FK; Saleh DO; Abdel Jaleel GA; Hussein RA; Hassan A
    Biomed Pharmacother; 2019 Aug; 116():109017. PubMed ID: 31158803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bovine lactoferrin improves bone mass and microstructure in ovariectomized rats via OPG/RANKL/RANK pathway.
    Hou JM; Xue Y; Lin QM
    Acta Pharmacol Sin; 2012 Oct; 33(10):1277-84. PubMed ID: 22902986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dietary calcium to available phosphorus ratios on bone metabolism and osteoclast activity of the OPG /RANK/RANKL signalling pathway in piglets.
    Zhao L; Li M; Sun H
    J Anim Physiol Anim Nutr (Berl); 2019 Jul; 103(4):1224-1232. PubMed ID: 31062421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatase and Rutile TiO
    Cheng W; Xu X; Lang Y; Cheng Z; Rizwan M; Tang X; Xie L; Liu Y; Xu H; Liu Y
    Int J Nanomedicine; 2021; 16():7233-7247. PubMed ID: 34737562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.
    Li X; Ominsky MS; Stolina M; Warmington KS; Geng Z; Niu QT; Asuncion FJ; Tan HL; Grisanti M; Dwyer D; Adamu S; Ke HZ; Simonet WS; Kostenuik PJ
    Bone; 2009 Oct; 45(4):669-76. PubMed ID: 19539794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Zuoguiwan on osteoporosis in ovariectomized rats through RANKL/OPG pathway mediated by β2AR.
    Liu F; Tan F; Tong W; Fan Q; Ye S; Lu S; Teng Z; Han M; Zhang M; Chai Y
    Biomed Pharmacother; 2018 Jul; 103():1052-1060. PubMed ID: 29710663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electroacupuncture Intervention Improves Cartilage Degeneration and Subchondral Bone Osteoporosis of Knee-joint Possibly by Adjusting OPG/RANK/RANKL Signaling in Ovariectomized Rats].
    Sun GH; Liao Y; Liao Y; Ni ZY; Li N; Zhong PR; Li XH; Zhou J
    Zhen Ci Yan Jiu; 2018 Dec; 43(12):781-7. PubMed ID: 30585456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J; Xu K; Wen G; Guo H; Li S; Wu X; Dai R; Sheng Z; Liao E
    Bone; 2008 May; 42(5):950-9. PubMed ID: 18337202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-34a alleviates steroid-induced avascular necrosis of femoral head by targeting Tgif2 through OPG/RANK/RANKL signaling pathway.
    Peng WX; Ye C; Dong WT; Yang LL; Wang CQ; Wei ZA; Wu JH; Li Q; Deng J; Zhang J
    Exp Biol Med (Maywood); 2017 Jun; 242(12):1234-1243. PubMed ID: 28454497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strontium fructose 1,6-diphosphate prevents bone loss in a rat model of postmenopausal osteoporosis via the OPG/RANKL/RANK pathway.
    Ma B; Zhang Q; Wu D; Wang YL; Hu YY; Cheng YP; Yang ZD; Zheng YY; Ying HJ
    Acta Pharmacol Sin; 2012 Apr; 33(4):479-89. PubMed ID: 22426695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dried plum prevents bone loss in a male osteoporosis model via IGF-I and the RANK pathway.
    Franklin M; Bu SY; Lerner MR; Lancaster EA; Bellmer D; Marlow D; Lightfoot SA; Arjmandi BH; Brackett DJ; Lucas EA; Smith BJ
    Bone; 2006 Dec; 39(6):1331-42. PubMed ID: 16890505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RANK/RANKL/OPG system in the intervertebral disc.
    Takegami N; Akeda K; Yamada J; Sano T; Murata K; Huang J; Masuda K; Sudo A
    Arthritis Res Ther; 2017 Jun; 19(1):121. PubMed ID: 28576140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein and Silicon Synergistically Protects Against Ovariectomy-Induced Bone Loss Through Upregulating OPG/RANKL Ratio.
    Chen C; Zheng H; Qi S
    Biol Trace Elem Res; 2019 Apr; 188(2):441-450. PubMed ID: 30014283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling.
    Jiang Y; Zhang Y; Chen W; Liu C; Li X; Sun D; Liu Z; Xu Y; Mao X; Guo Q; Lin N
    J Transl Med; 2014 Nov; 12():334. PubMed ID: 25471933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoprotective Effect of Cimiracemate in Glucocorticoid-Induced Osteoporosis by Osteoprotegerin/Receptor Activator of Nuclear Factor κ B/Receptor Activator of Nuclear Factor Kappa-Β Ligand Signaling.
    Ding Z; Shi H; Yang W
    Pharmacology; 2019; 103(3-4):163-172. PubMed ID: 30695776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc supplements and bone health: The role of the RANKL-RANK axis as a therapeutic target.
    Amin N; Clark CCT; Taghizadeh M; Djafarnejad S
    J Trace Elem Med Biol; 2020 Jan; 57():126417. PubMed ID: 31653549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine alleviates oxidative stress in rats with osteoporosis through receptor activator of NF-kB/receptor activator of NF-kB ligand/osteoprotegerin (RANK/RANKL/OPG) pathway.
    He XF; Zhang L; Zhang CH; Zhao CR; Li H; Zhang LF; Tian GF; Guo MF; Dai Z; Sui FG
    Bosn J Basic Med Sci; 2017 Nov; 17(4):295-301. PubMed ID: 29055350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
    Armada L; Marotta Pdos S; Pires FR; Siqueira JF
    J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.